I-CBP112 hydrochloride
Based on 5 publication(s) in Google Scholar
I-CBP112 hydrochloride is a selective inhibitor of CBP/P300 that directly binds their bromodomains (Kds = 142 and 625 nM, respectively). I-CBP112 significantly reduces the leukemia-initiating potential of MLL-AF9(+) acute myeloid leukemia cells in a dose-dependent manner in vitro and in vivo. I-CBP112 increases the cytotoxic activity of BET bromodomain inhibitor JQ1 as well as doxorubicin.
For research use only. We do not sell to patients.
- CAS No.: 2147701-33-3
- Formula: C27H37ClN2O5
- Molecular Weight:505.05
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) I-CBP112 hydrochloride
More
Biological Activity
Chemical Information
-
CAS No. 2147701-33-3
-
Molecular Weight 505.05
-
Formula C27H37ClN2O5
-
SMILES
CCC(N1CCOC2=C(OC[C@@H]3CN(C)CCC3)C=C(C4=CC=C(OC)C(OC)=C4)C=C2C1)=O.[H]Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
Cell
Fibroblasts of disparate developmental origins harbor anatomically variant scarring potential. [Abstract]2026 Feb 5;189(3):783-799.e20. PMID: 41576949 -
Cell Res
2021 Mar;31(3):291-311. PMID: 33299139 -
Nat Commun
Human iPSC-based Modeling of Pulmonary Fibrosis Reveals p300/CBP Inhibition Suppresses Alveolar Transitional Cell State. [Abstract]2026 Feb 12;17(1):1214. PMID: 41680175 -
iScience
Transcriptional synergy in human aortic endothelial cells is vulnerable to combination p300/CBP and BET bromodomain inhibition. [Abstract]2024 May 16;27(6):110011. PMID: 38868181 -
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)